Fesoterodine: all 47 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• Fall Prevention in Older Adults With OABCompletedNCT03946124Phase 4Results posted
• Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE)CompletedNCT01786967Phase 3Results posted
• Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine FumarateTerminatedNCT01605617Phase 4Results posted
• Comparative Urine Proteomic Studies of Overactive Bladder in HumansCompletedNCT01367886Not applicableResults posted
• A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of FesoterodineCompletedNCT01302067Phase 4Results posted
• A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.CompletedNCT01302054Phase 4Results posted
• This Is A Study Of Bioavailability And Food Effect For Fesoterodine.CompletedNCT01286454Phase 1Results posted
• A Study to Assess the Cognitive Effects of Fesoterodine in Elderly SubjectsCompletedNCT01161472Phase 1Results posted
• Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive BladderCompletedNCT01054222Phase 4Results posted
• Evaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence PatientsCompletedNCT01042236Phase 2Results posted
• A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive BladderCompletedNCT00928070Phase 4Results posted
• A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary UrgencyCompletedNCT00911937Phase 4Results posted
• Bringing Simple Urge Incontinence Diagnosis & Treatment to Providers (BRIDGES)CompletedNCT00862745Phase 4Results posted
• Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 YearsCompletedNCT00857896Phase 2Results posted
• Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal TransitTerminatedNCT00832650Phase 1Results posted
• UK Study Assessing Flexible Dose Fesoterodine in AdultsCompletedNCT00806494Phase 4Results posted
• A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder.CompletedNCT00798434Phase 4Results posted
• Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder.CompletedNCT00658684Phase 3Results posted
• Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.CompletedNCT00611026Phase 3Results posted
• An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic HyperplasiaCompletedNCT00605319Phase 4Results posted
• Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.CompletedNCT00561951Phase 2Results posted
• Fesoterodine "add-on" Male Overactive Bladder StudyCompletedNCT00546637Phase 3Results posted
• Fesoterodine Flexible Dose StudyCompletedNCT00536484Phase 3Results posted
• Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)CompletedNCT00444925Phase 3Results posted
• A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder PatientsCompletedNCT00425100Phase 3Results posted
• Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI)CompletedNCT02676154Phase 2
• Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children.CompletedNCT02614482Phase 3
• Fesoterodine on Urgency Episodes in Parkinson's Disease PopulationTerminatedNCT02385500Phase 4
• Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in ChildrenCompletedNCT02327936Phase 3
• Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and OlderTerminatedNCT02262936Phase 2/3
• A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive ImpairmentCompletedNCT02240459Phase 2
• Validation of Instruments for Pragmatic Clinical Trials for Overactive BladderCompletedNCT01925456Phase 1
• A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. ProstatectomyCompletedNCT01661166Phase 4
• Solifenacin Succinate Versus Fesoterodine A Comparison Trial for Urgency SymptomsStatus unknownNCT01595152Not applicable
• A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy VolunteersCompletedNCT01566760Phase 1
• The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy SubjectsCompletedNCT00914667Phase 1
• The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy SubjectsCompletedNCT00911235Phase 1
• A Bioequivalence Study Of 8 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy SubjectsCompletedNCT00902681Phase 1
• A Bioequivalence Study Of 4 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy SubjectsCompletedNCT00902187Phase 1
• Phase 1, Single Dose, Crossover Study to Determine Bioequivalence and to Investigate Food EffectCompletedNCT00807118Phase 1
• Phase1, Single Dose, Crossover Study to Determine BioequivalenceCompletedNCT00786240Phase 1
• Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke PatientsWithdrawnNCT00713921Early Phase 1
• Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder SyndromeCompletedNCT00220402Phase 3
• Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension PhaseCompletedNCT00220389Phase 2
• Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder SyndromeCompletedNCT00220376Phase 3
• A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder SyndromeCompletedNCT00220363Phase 3
• Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder SyndromeCompletedNCT00138723Phase 3

← Fesoterodine overview